SCHEMBL30692639

SCHEMBL30692639

Cc1cc(Nc2ncc(Cl)c(Nc3cc(Cl)ccc3NS(C)(=O)=O)n2)c(Cl)cc1N1CCC(N2CCC(N(C)C)C2)CC1

nearest known ligand 0.56

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 18/20 0.56
▸ ALK Q9UM73 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26906887 1.00 EGFR (0.56) EGFRALK
SCHEMBL26906509 0.94 EGFR (0.57) EGFRALK
SCHEMBL26906545 0.92 EGFR (0.58) EGFRALK
SCHEMBL26906607 0.90 EGFR (0.53) EGFR
SCHEMBL26906811 0.90 EGFR (0.53) EGFRALK
SCHEMBL26906829 0.88 EGFR (0.56) EGFR
SCHEMBL26906536 0.88 EGFR (0.64) EGFRALK
SCHEMBL26906843 0.87 EGFR (0.61) EGFRALK
SCHEMBL26906882 0.87 EGFR (0.49) EGFRALK
SCHEMBL26906652 0.87 EGFR (0.66) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4286376-A1 PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME Therapex Co., Ltd. (KR) 2023-12-06 — — EP disclosed
Send feedback